Abstract Introduction UK drug related deaths are at their highest since records began, considerably higher than the rest of Europe. There were 3,744 registered deaths in 2016 and of these, 54% involved heroin. The number of people with co-existing mental health problems within drug treatment is estimated to be between 60-93% yet only 4% of people accessing treatment are estimated to receive integrated substance use disorder and mental health treatment. Methods This was a two phase project;1) an analysis of all opioid related deaths in England between 2006 and 2015 recorded in NPSAD was conducted (n=10,461) to identify how many had a recorded co-existing mental health problem diagnosis2) an interpretative phenomological analysis from interviews involving both drug and mental health practitioners regarding attitudes towards treatment of the population. Results Diagnosis of co-existing mental health problems was reported to be lower than the prevalence of the general population and significantly lower than expected in opioid users.Where diagnosis was recorded, life expectancy exceeded those without diagnosis by 9.87 months (15-24 group), 2 months (35-44 group), 4.2 months (45-54 group), and 3.1 months (55-64). In two cohorts life expectancy was shortened by 2 months (25-34 group) and 5.4 years (65 and over group).One psychotherapist stated ‘there is no secondary care pathway for substance misuse, if we see them it is by accident'ConclusionThis analyses shows a significant under diagnosis of co-existing mental health problems therefore treatment is unlikely to have included psychological intervention, vital in supporting this vulnerable population. External funding details
Abstract Introduction UK drug related deaths are at their highest since records began, considerably higher than the rest of Europe. There were 3,744 registered deaths in 2016 and of these, 54% involved heroin. The number of people with co-existing mental health problems within drug treatment is estimated to be between 60-93% yet only 4% of people accessing treatment are estimated to receive integrated substance use disorder and mental health treatment. Methods This was a two phase project;1) an analysis of all opioid related deaths in England between 2006 and 2015 recorded in NPSAD was conducted (n=10,461) to identify how many had a recorded co-existing mental health problem diagnosis2) an interpretative phenomological analysis from interviews involving both drug and mental health practitioners regarding attitudes towards treatment of the population. Results Diagnosis of co-existing mental health problems was reported to be lower than the prevalence of the general population and significantly lower than expected in opioid users.Where diagnosis was recorded, life expectancy exceeded those without diagnosis by 9.87 months (15-24 group), 2 months (35-44 group), 4.2 months (45-54 group), and 3.1 months (55-64). In two cohorts life expectancy was shortened by 2 months (25-34 group) and 5.4 years (65 and over group).One psychotherapist stated ‘there is no secondary care pathway for substance misuse, if we see them it is by accident'ConclusionThis analyses shows a significant under diagnosis of co-existing mental health problems therefore treatment is unlikely to have included psychological intervention, vital in supporting this vulnerable population. External funding details
By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS). USER TERMS AND CONDITIONS | PRIVACY POLICY
Cookie Settings
Accept Terms & all Cookies
Anonymous User Privacy Preferences
Strictly Necessary Cookies (Always Active)
MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.
Performance Cookies
Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.